A. Dunky

发表

Pamidronate increases bone mineral density in women with postmenopausal or steroid‐induced osteoporosis

E. Cauza, G. Partsch, H. Noske, 2004, Journal of clinical pharmacy and therapeutics.

Meclofenamate sodium in the treatment of acute gout. Results of a double-blind study.

R. Eberl, A. Dunky, 1983, Arzneimittel-Forschung.

HLA-B27 determination using serological methods. A comparison of enzyme immunoassay and a microlymphocytotoxic test with flow cytometry and a molecular biological assay

W. Mayr, P. Bayer, J. Neumüller, 2005, Rheumatology International.

Third Eular Workshop on Rheumatology Research

C. Forbes, R. Madhok, A. Cats, 1983, Clinical Rheumatology.

Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.

P. Welling, A. Sedman, A. Black, 1988, The Journal of antimicrobial chemotherapy.

Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid.

B. Leeb, J. Smolen, H. Bröll, 1997, The Journal of rheumatology.

Interaction of monocytes from patients with psoriatic arthritis with cultured microvascular endothelial cells.

H. Burtscher, J. Neumüller, R. Jilch, 2001, Clinical immunology.

Transsynovial kinetics of piroxicam in patients with rheumatoid arthritis

M. Kurowski, A. Dunky, 2004, European Journal of Clinical Pharmacology.

Decisive Diagnosis of Seronegative Polyarthritis by 3-phase Bone Scintigraphy

S. Mirzaei, P. Knoll, E. Wagner, 1998, Nuklearmedizin.

Interactions of lymphocytes from patients with psoriatic arthritis or healthy controls and cultured endothelial cells.

J. Neumüller, J. Menzel, A. Dunky, 1997, Clinical immunology and immunopathology.

The clinical pharmacokinetics and tolerance of enoxacin in healthy volunteers.

J. Goulet, R. Eberl, A. Dunky, 1984, The Journal of antimicrobial chemotherapy.

Inhibition of complement activation in aged individuals due to increased plasma fibronectin concentration

J. Menzel, A. Dunky, 1989, Experimental Gerontology.

Comparative clinical trial with a new substance, Diftalone, versus indomethacin in 30 patients affected with rheumatoid arthritis.

H. Bröll, R. Eberl, A. Dunky, 1976, Scandinavian journal of rheumatology.

Modulation of the migration and chemotaxis of PMN cells by hyaluronic acid.

C. Schwarzer, J. Neumüller, P. Petera, 1989, Zeitschrift fur Rheumatologie.

Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid.

B. Leeb, J. Smolen, G. Steiner, 1998, The Journal of rheumatology.

Hyaluronic acid in the treatment of osteoarthritis of the knee joint: interim results of a comparative clinical study

G. Kolarz, R. Kotz, H. Bröll, 1995 .

European double-blind multicenter study comparing meclofenamate sodium and indomethacin in the treatment of rheumatoid arthritis.

H. Mattern, A. Dunky, 1983, Arzneimittel-Forschung.